NCT03783000View on ClinicalTrials.gov

A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

March 6, 2019

Study Completion Date

March 6, 2019

Conditions
Healthy
Interventions
DRUG

BI 425809

Treatment T

DRUG

BI 425809 mixed with [C-14]-BI 425809

Treatment R

Trial Locations (1)

9728 NZ

PRA Health Sciences Onderzoekscentrum Martini, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03783000 - A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet | Biotech Hunter | Biotech Hunter